AbbVie
ABBV
ABBV
2,359 hedge funds and large institutions have $106B invested in AbbVie in 2020 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 1,060 increasing their positions, 910 reducing their positions, and 129 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
16% less first-time investments, than exits
New positions opened: 109 | Existing positions closed: 129
29% less call options, than puts
Call options by funds: $1.35B | Put options by funds: $1.89B
39% less funds holding in top 10
Funds holding in top 10: 197 → 121 (-76)
Holders
2,359
Holding in Top 10
121
Calls
$1.35B
Puts
$1.89B
Top Buyers
| 1 | +$1.86B | |
| 2 | +$300M | |
| 3 | +$260M | |
| 4 |
Morgan Stanley
New York
|
+$114M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
+$106M |
Top Sellers
| 1 | -$792M | |
| 2 | -$486M | |
| 3 | -$464M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$267M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$259M |